James Gurney - Evolution-informed strategies to improve efficacy and evolutionary robustness of phage therapy: phage steering and phage re-use

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Event Details
  • Date/Time:
    • Friday February 5, 2021 - Saturday February 6, 2021
      3:00 pm - 3:59 pm
  • Location: https://bluejeans.com/990364159
  • Phone:
  • URL: https://bluejeans.com/990364159
  • Email:
  • Fee(s):
    N/A
  • Extras:
Contact

 

 

 

 

Summaries

Summary Sentence: CMDI Seminar Series 2021

Full Summary: No summary paragraph submitted.

James's will be giving a practice job talk, entitled: Evolution-informed strategies to improve efficacy and evolutionary robustness of phage therapy: phage steering and phage re-use

 

 

Phage therapy has the potential to treat currently intractable infections, yet multiple challenges remain over initial efficacy and also over the rapidity of failure due to the evolution of resistance.  

Focusing on phages of the major opportunistic pathogen Pseudomonas aeruginosa, I will demonstrate a series of novel phage therapy strategies that can extend the effective use of phages by harnessing their evolutionary potential, including the predictable co-evolutionary dynamics that play out between bacteria and phage. Specifically, I will introduce ‘phage steering’, featuring the use of targeted phages to both kill and also select against pathogenic phenotypes among surviving bacteria (reducing virulence and drug resistance). I will also discuss ‘phage re-use’, featuring the targeted implementation of specific co-evolutionary mechanisms to allow for repeated use of a single, standardized (i.e. FDA approvable) phage therapy. I conclude with a survey of the clinical relevance of my results, with a focus on chronic infections. 

Additional Information

In Campus Calendar
No
Groups

Invited Audience
Faculty/Staff, Public, Undergraduate students
Categories
No categories were selected.
Keywords
No keywords were submitted.
Status
  • Created By: mavdonina3
  • Workflow Status: Error
  • Created On: Feb 5, 2021 - 12:39pm
  • Last Updated: Feb 5, 2021 - 12:39pm